(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylindolo[2,3-b]quinolin-9-yl)oxyethoxy]-2-methyloxan-3-ol
Compound with spectra: 1 NMR
![(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylindolo[2,3-b]quinolin-9-yl)oxyethoxy]-2-methyloxan-3-ol](/api/compound/6Vkdv8AQV2r.png?ph=true&h=300&w=458 "(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylindolo[2,3-b]quinolin-9-yl)oxyethoxy]-2-methyloxan-3-ol")
| SpectraBase Compound ID | 6Vkdv8AQV2r |
|---|---|
| InChI | InChI=1S/C25H29N3O4/c1-14-17-6-4-5-7-21(17)28(3)25-23(14)18-12-16(8-9-20(18)27-25)30-10-11-31-22-13-19(26)24(29)15(2)32-22/h4-9,12,15,19,22,24,29H,10-11,13,26H2,1-3H3/t15-,19-,22+,24-/m0/s1 |
| InChIKey | ZXSLBESVGOTAIQ-QRFLKLNRSA-N |
| Mol Weight | 435.52 g/mol |
| Molecular Formula | C25H29N3O4 |
| Exact Mass | 435.215806 g/mol |
| Enantiomer InChIKey | ZXSLBESVGOTAIQ-XPQXFEHLSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
LINIRBCEAIIEOG-KLNIMBRESA-N
OPCQZBJSWFSRJZ-UHFFFAOYSA-N
(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylquinolino[2,3-b]indol-2-yl)oxyethoxy]-2-methyloxan-3-ol
(2S,3S,4S,6R)-4-amino-6-[5-(5,11-dimethylquinolino[2,3-b]indol-2-yl)oxypentoxy]-2-methyloxan-3-ol
LFURAYQVUIBSRP-UHFFFAOYSA-N
2-METHYL-11-TRIMETHYLSILYL-NEOCRYPTOLEPINE
11-TRIMETHYLSILYL-NEOCRYPTOLEPINE
13-Dehydro-15(14)anhydroserratine
5,3',4',2'''-TETRAHYDROXY-2'',2''-DIMETHYLPYRANO-(5'',6'':7,8)-6-(3'''-METHYL-3'''-BUTENYL)-ISOFLAVONE
(6aS,8S,10bR,12aS)-3,3,6a,8,10b,12a-hexamethyl-1,2,3,4,5,6,6a,7,8,9,10,10a,10b,11,12,12a-hexadecahydrochrysen-2-yl acetate
| Title | Journal or Book | Year |
|---|---|---|
| 1H and13C NMR data for indolo[2,3-b]quinoline–aminoglycoside hybrids, a novel potent anticancer drug family | Magnetic Resonance in Chemistry | 2006 |